Oropouche Virus Test Introduced by Quest Diagnostics
Quest Diagnostics has launched a new PCR-based diagnostic test for the Oropouche virus, enhancing preparedness for this emerging disease.
Tag: Zika Virus
All
Latest
All
Latest
BBI Solutions Demonstrates Internal Antibody Development Capabilities
BBI Solutions adds four new antibodies for HIV-1 with plans to expand offerings related to chikungunya virus, Dengue virus, norovirus, and Zika virus.
All
LatestFrom the Editor: Refining Zika Testing
At the beginning of May, the US Centers for Disease Control and Prevention issued a health advisory to update clinicians about the use of serologic testing for Zika virus among pregnant women.
FDA Expands Emergency Use Authorization for Hologic Zika Virus Assay
Previously authorized for emergency use with serum and plasma samples, the assay is now authorized to be used with urine samples, lengthening the time period during which patients can be tested for Zika from 7 days to 14 days following the onset of symptoms.
Read More
BioLytical Laboratories Announces US Patent Filings for Zika Detection Assays
The patent applications expand the company’s growing intellectual property portfolio, and include an immunoassay system for the detection of antibodies to such pathogens as Zika and other flaviviruses.
Read More
From the Editor: New Guidance on Zika Testing
FDA’s Center for Biologics Evaluation and Research recently issued a revised guidance document to reduce the risk of Zika virus transmission through donated blood and blood components.
Read More
CDC Steps Up Emergency Response to Florida Zika Outbreak
To date, CDC has shipped enough material for Florida to conduct 6,300 Zika antibody tests.
Read More
FDA Continues EUA Allowances for Zika Diagnostics
A molecular diagnostic from Luminex is the latest to receive emergency use authorization to detect Zika virus.
Read More
Siemens Zika Assay Receives FDA EUA
The PCR-based kit is capable of detecting the presence of Zika virus, which can be an earlier indicator of Zika virus infection than anti-Zika antibodies.
Read More
Zika Monoclonal Antibodies Function in IFA
The new antibodies do not crossreact with related flaviviruses tested, nor with chikungunya virus.
Read More
CDC Issues Zika Travel Guidance for Miami Neighborhood
New assessments of mosquito populations and test results by Florida public health officials suggest there is a risk of continued active transmission.
Read MoreHHS Awards $5.1 Million to InBios to Advance Zika Diagnostic
Serological test may be able to return results in about 4 hours, and could be used in commercial and healthcare facility laboratories.
Read More
Zika Spreads Through Puerto Rico
The US Centers for Disease Control and Prevention cautions that widespread Zika infections warrant urgent action to protect pregnant women.
Read More
FDA Approves Use of Zika Virus Assay to Screen US Blood Supply
Blood centers will use the assay to screen donated blood collected in potential endemic areas of the southern United States.
Read More
FDA Grants Emergency Use Authorization for Zika Virus Assay
The diagnostic test from Hologic is now available for use on 
the fully automated Panther system.
Read More
Reference Material Covers Entire Zika Virus Genome
Based on recombinant virus technology, the new reference material provides a safe, non-replicative, and fully extractable positive material.
Read More
CDC to Award Zika Preparation Funds
More than $85 million in redirected funds identified by the Department of Health and Human Services is being made available to support efforts to protect Americans from Zika infection and associated adverse health outcomes.
Read More
Real-Time PCR Zika Test Granted Emergency Use Authorization
Altona Diagnostics’ test enables qualitative detection of RNA from Zika virus in persons meeting clinical or epidemiological criteria set by the US Centers for Disease Control and Prevention.
Read More